Is there a place for inhaled antibiotics? Figure 2 @JiaoLiu https://t.co/DIQJlw0Ypw #MechanicalVentilation #Aerosol #Antibiotics #AIC #FICS #SRLF https://t.co/r8e4kC1orh
RT @SCCM_CPP: #CPPPLUHighlights: This recent trial from @of_AIC found no improvement in clinical cure with inhaled polymyxin B plus IV poly…
RT @SCCM_CPP: #CPPPLUHighlights: This recent trial from @of_AIC found no improvement in clinical cure with inhaled polymyxin B plus IV poly…
#CPPPLUHighlights: This recent trial from @of_AIC found no improvement in clinical cure with inhaled polymyxin B plus IV polymyxin B compared to IV polymyxin B alone in XDR Gram-negative bacilli VAP patients. #PharmICU https://t.co/UxR8keji45
https://t.co/vKMNaor2W7 広域薬剤耐性GNRによるVAPに対し、IV単独とポリミキシンBの吸入+IVを比べた後ろ向き研究 結果は、治癒率(43.2vs27.3%),細菌消失率(36.4vs23.9%),VAP関連死亡率(27.3vs34.1%),全因死亡率(34.1vs42.0%)は差がなかったが、臨床転機は併用群で良好だった(77.3vs58.0%) #当麻_感染